Search results for "Highlights"


 
Results 41 - 50 of about 352 for "Highlights".

Highlights

Our findings provide a useful basis for the evaluation of the multifactorial approaches to both remission and prevention of diabetes that are currently being introduced and also highlight the need for
November 2021

Highlights

The trial of semaglutide included 3,297 patients with type 2 diabetes, 83% of whom had established cardiovascular disease, chronic kidney disease, or both.
October 2016

Highlights

A study used simulation modeling to project the long-term effects of a three-month exercise and cognitive behavioral therapy (CBT) intervention for patients with type 2 diabetes and major depressive disorder. It found clear cost-effectiveness with
March 2021

From ACP Journal Club

The KDIGO guidelines highlight the importance of treating patients who have diabetes, hypertension, and albuminuria with an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker.
March 2021

Highlights

The Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial, which was funded by Novo Nordisk and the National Institutes of Health, randomized 9,340 patients ages 50 years and older to 1.8 mg of
July 2016

Highlights

These recommendation are part of a consensus report by the two organizations that highlights major areas of care for clinicians managing adults with type 1 diabetes, focusing primarily on current and
October 2021

Highlights

Prior metformin use was associated with a threefold decrease in mortality from COVID-19 in one study of patients with type 2 diabetes, while three other studies found mixed results on whether dipeptidyl peptidase-4 (DPP-4) inhibitors affect COVID-19
February 2021

Highlights

The score, which was based on cardiac troponin, N-terminal pro-B-type natriuretic peptide, C-reactive protein, and electrocardiography, could be used to target specific therapies to the highest-risk patients, study authors said.
January 2021

Highlights

Risk factor control was more strongly associated with mortality risk among patients with cardiorenal disease than those without, according to a retrospective British study.
December 2020

Highlights

A randomized trial found equivalent improvements in visual acuity at two years with either therapy but identified some differences in outcomes that could help patients and clinicians choose a treatment method.
January 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next